Metagenomi Therapeutics (MGX) Change in Receivables (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Change in Receivables of -$305000.0 for Q1 2026, down 24.49% year-over-year from -$403918.9 in Q1 2025, and up 53.44% quarter-over-quarter from -$655000.0 in Q4 2025.
Metagenomi Therapeutics (MGX) Change in Receivables (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Change in Receivables data on file, last reported at -$305000.0 in Q1 2026.
- Change in Receivables for Q1 2026 came in at -$305000.0, down 24.49% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 million (up 5.42% YoY), and the FY2025 annual result was -$952000.0, up 20.27% from the prior year.
- Change in Receivables advanced to -$305000.0 in Q1 2026 per MGX's latest filing, from -$655000.0 in the prior quarter.
- Over five years, Change in Receivables peaked at $1.6 million in Q3 2023 and troughed at -$1.5 million in Q4 2023.
- A 4-year average of -$211636.4 and a median of -$305000.0 in 2026 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2024 and 2025: Change in Receivables jumped 145.35% in 2024, then tumbled 198.05% in 2025.
- A 4-year view of Change in Receivables shows it stood at -$1.5 million in 2023, then jumped by 145.35% to $668000.0 in 2024, then slumped by 198.05% to -$655000.0 in 2025, then soared by 53.44% to -$305000.0 in 2026.
- Business Quant data shows MGX's Change in Receivables at -$305000.0 in Q1 2026, -$655000.0 in Q4 2025, and $87000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | 22,529.00 |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | -39.80 Mn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -4.08 Mn |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | -305,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -305,000.00 |
| Mar 31, 2026 | -305,000.00 |
| Dec 31, 2025 | -655,000.00 |
| Dec 31, 2025 | -655,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Sep 30, 2025 | 87,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Jun 30, 2025 | -139,000.00 |
| Mar 31, 2025 | -245,000.00 |
| Mar 31, 2025 | -245,000.00 |
| Dec 31, 2024 | 668,000.00 |
| Dec 31, 2024 | 668,000.00 |
| Sep 30, 2024 | -1.06 Mn |
| Sep 30, 2024 | -1.06 Mn |
| Jun 30, 2024 | -434,000.00 |
| Jun 30, 2024 | -434,000.00 |
| Mar 31, 2024 | -369,000.00 |
| Mar 31, 2024 | -369,000.00 |
| Dec 31, 2023 | -1.47 Mn |
| Dec 31, 2023 | -1.47 Mn |